October 16, 2020
The full Federal Circuit Friday rejected a bid from Bristol-Meyers and others for review of a panel decision that two American scientists from the Dana-Farber Cancer Institute should be named as co-inventors on six patents involved in Nobel Prize-winning cancer research.
September 15, 2020
The Dana-Farber Cancer Institute is urging the full Federal Circuit not to reconsider a panel decision requiring a pair of American scientists to be named as co-inventors on patents involved in Nobel Prize-winning cancer research.
July 14, 2020
The Federal Circuit on Tuesday affirmed that a pair of American scientists should be named as co-inventors on six patents involved in Nobel Prize-winning cancer research, finding Ono Pharmaceutical was trying to push "an unnecessarily heightened inventorship standard."
July 09, 2020
A wave of U.S. Supreme Court petition denials has made 2020 a bit of a letdown for patent attorneys, but there are several high-profile cases on the horizon that could decide the fate of Patent Trial and Appeal Board judges and biosimilars law, and offer more clarity on licensing standard essential patents.
May 08, 2020
A Federal Circuit panel grappled Friday with where to draw the line between collaboration and significant contributions in determining whether a district court wrongly ordered two scientists to be named as co-inventors on six patents involved in Nobel Prize-winning cancer research.